Moderate essential hypertension control: a double-blind crossover study between a serotonin antagonist and a...

Area of Science:

• Cardiology
• Pharmacology

Background:

• Essential hypertension is a common condition characterized by elevated blood pressure.
• Antihypertensive medications aim to reduce blood pressure by affecting vascular resistance and cardiac load.
• Understanding the distinct mechanisms of action for different drug classes is crucial for effective treatment.

Purpose of the Study:

• To compare the efficacy of ketanserin, a serotonin antagonist, with prazosin, a post-synaptic alpha-blocker, in treating essential hypertension.
• To investigate the hemodynamic effects and clinical outcomes of these two distinct antihypertensive agents.

Main Methods:

• A double-blind, crossover study design was employed.
• Patients received placebo, ketanserin, and prazosin over distinct treatment periods.
• Blood pressure was measured in multiple positions (supine, sitting, standing) throughout the study.

Main Results:

• Both ketanserin and prazosin significantly reduced blood pressure in patients with essential hypertension.
• Ketanserin demonstrated a potential for greater reduction in afterload compared to prazosin.
• No dosage titration was required for ketanserin, unlike prazosin.

Conclusions:

• Ketanserin is an effective antihypertensive agent, comparable in efficacy to prazosin.
• Ketanserin's simpler dosing regimen (twice daily) may lead to improved patient compliance.
• The distinct mechanisms of action suggest different hemodynamic profiles, with ketanserin potentially impacting afterload more significantly.